Prévenir la toxicité d'une aliment grâce à la Data Science - Abdoul Traoré

•

0 likes•345 views

This document discusses using machine learning algorithms for chemical toxicity classification from a data science bootcamp. It notes that over 122 million chemical products exist with 11,000 new substances introduced daily. Traditional toxicity testing is limited as little toxicology information is available for many chemicals. The document examines using machine learning methods like XGBoost that can predict biological responses with around 80% accuracy as an alternative to traditional approaches. Applications are mentioned for detecting toxic substances and for use by chemists, biologists, and pharmaceutical companies.

Data Science Bootcamp
Bioinformatics: machine learning
algorithms for chemical toxicity
classification
Abdoul K. TRAORE

Is the ML algorithms relevant
for for chemical toxicity
classification ?

Ø  CAS database : 122 M of chemical products in 2017
against 18M in 2002
Ø  11 000 new substances / day
Ø  85000 chemical are commercially available and 7 new
substances are introduced into the marketplace each day
Some figures

Background: how to determine the toxicity of a
chemical ?
Ø  Little toxicology information is available

Background: traditional toxicity testing approaches

Is the ML algorithms relevant
for for chemical toxicity
classification ?
>80%

Predicting a biological response
XGBoost: ~80% Accuracy

Alternative biological mechanisms : ML methods
Judson et al. 2008

Predicting a biological response
Data:
Ø  3751 molecules (rows)
Ø  1776 features (molecular descriptors )
Ø  Positif biological response (1)
Ø  Or not (0)

Predicting a biological response
Target
variable

Predicting a biological response: comparison of
machine learning algorithms

Applications
Ø  Application pour déceler les substances toxiques:
Yuka, Inci Beauty, Pharmapocket
Ø  Chimistes et biologistes
Ø  Pharmaceutique

Data Science Bootcamp
Merci ! A la prochaine :)

There is a growing need for rapid chemical screening and prioritization to inform regulatory decision-making on thousands of chemicals in the environment. We have previously used high-resolution mass spectrometry to examine household vacuum dust samples using liquid chromatography time-of-flight mass spectrometry (LC-TOF/MS). Using a combination of exact mass, isotope distribution, and isotope spacing, molecular features were matched with a list of chemical formulas from the EPA’s Distributed Structure-Searchable Toxicity (DSSTox) database. This has further developed our understanding of how openly available chemical databases, together with the appropriate searches, could be used for the purpose of compound identification. We report here on the utility of the EPA’s iCSS Chemistry Dashboard for the purpose of compound identification using searches against a database of over 720,000 chemicals. We also examine the benefits of QSAR prediction for the purpose of retention time prediction to allow for alignment of both chromatographic and mass spectral properties. This abstract does not reflect U.S. EPA policy.

Structure Identification Using High Resolution Mass Spectrometry Data and the...

US Environmental Protection Agency (EPA), Center for Computational Toxicology and Exposure

The iCSS Chemistry Dashboard is a publicly accessible dashboard provided by the National Center for Computation Toxicology at the US-EPA. It serves a number of purposes, including providing a chemistry database underpinning many of our public-facing projects (e.g. ToxCast and ExpoCast). The available data and searches provide a valuable path to structure identification using mass spectrometry as the source data. With an underlying database of over 720,000 chemicals, the dashboard has already been used to assist in identifying chemicals present in house dust. However, it can also be applied to many other purposes, e.g., the identification of agrochemicals in waste streams. This presentation will provide a review of the EPA’s platform and underlying algorithms used for the purpose of compound identification using high-resolution mass spectrometry data. We will also discuss progress towards a high-throughput non-targeted analysis platform for use by the mass spectrometry community. This abstract does not reflect U.S. EPA policy.

The EPA iCSS Chemistry Dashboard to Support Compound Identification Using Hig...

Andrew McEachran

Structure identification using high resolution mass spectrometry data and the...

Andrew McEachran

Crofton Evolution of Toxicology

KevinCrofton

Talk at Yale University April 26th 2011: Applying Computational Modelsfor To...

Sean Ekins

The document discusses applying computational models to problems in toxicology, drug discovery, and beyond. It summarizes recent work using machine learning models and other in silico techniques to predict drug-induced liver injury (DILI) and interactions with transporters like hOCTN2. Models were able to classify compounds as DILI-positive or negative with over 75% accuracy when tested on external datasets. The techniques discussed could help prioritize compounds for further testing and filter libraries to avoid reactive or toxic features.

Introduction to Chemoinfornatics

SSA KPI

Dr. Igor V. Tetko introduces chemoinformatics, which uses informatics methods to solve chemical problems. It involves organizing and analyzing large chemical datasets. Key applications include drug discovery, chemical safety assessments like REACH, and predictive toxicology. Chemoinformatics helps address issues like high drug development costs and testing requirements by predicting properties in silico. The course covers topics like molecular representations, modeling techniques, and the online OCHEM database and modeling platform. Chemoinformatics aims to transform chemical data into knowledge to make better informed decisions.

Finland Helsinki Drug Research slides 2011

Sean Ekins

This document summarizes the application and future of ADME/Tox (Absorption, Distribution, Metabolism, Excretion and Toxicology) models. It discusses how combining in silico, in vitro and in vivo data can help evaluate these properties earlier in drug discovery. It also outlines how crowdsourcing and increased data and model sharing can help advance the field. Finally, it provides examples of Bayesian machine learning models that have been developed to predict various ADME/Tox endpoints.

Humans are potentially exposed to tens of thousands of man-made chemicals in the environment. It is well known that some environmental chemicals mimic natural hormones and thus have the potential to be endocrine disruptors. Most of these environmental chemicals have never been tested for their ability to disrupt the endocrine system, in particular, their ability to interact with the estrogen receptor. EPA needs tools to prioritize thousands of chemicals, for instance in the Endocrine Disruptor Screening Program (EDSP). This project was intended to be a demonstration of the use of predictive computational models on HTS data including ToxCast and Tox21 assays to prioritize a large chemical universe of 32464 unique structures for one specific molecular target – the estrogen receptor. CERAPP combined multiple computational models for prediction of estrogen receptor activity, and used the predicted results to build a unique consensus model. Models were developed in collaboration between 17 groups in the U.S. and Europe and applied to predict the common set of chemicals. Structure-based techniques such as docking and several QSAR modeling approaches were employed, mostly using a common training set of 1677 compounds provided by U.S. EPA, to build a total of 42 classification models and 8 regression models for binding, agonist and antagonist activity. All predictions were evaluated on ToxCast data and on an external validation set collected from the literature. In order to overcome the limitations of single models, a consensus was built weighting models based on their prediction accuracy scores (including sensitivity and specificity against training and external sets). Individual model scores ranged from 0.69 to 0.85, showing high prediction reliabilities. The final consensus predicted 4001 chemicals as actives to be considered as high priority for further testing and 6742 as suspicious chemicals. This abstract does not necessarily reflect U.S. EPA policy

Unc slides on computational toxicology

Sean Ekins

The document discusses computational models that have been and can be used for predicting human toxicities. It provides examples of models that have been developed for predicting various physicochemical properties, interactions with proteins, and toxicity outcomes like mutagenicity, environmental toxicity, and drug-induced liver injury. It also outlines future areas that could be modeled, like mixtures and more specific protein targets. The key enablers of these models are increased computing power and data availability from literature and open sources.

Slides for st judes

Sean Ekins

The document discusses collaborative drug discovery efforts for neglected diseases like tuberculosis. It describes how the Collaborative Drug Discovery (CDD) platform facilitates open data sharing and enables building predictive models across public and private datasets from multiple organizations. CDD has supported over 20 labs working on tuberculosis through cheminformatics analysis of large compound libraries and building Bayesian classification models to prioritize compounds for testing.

Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...

Sean Ekins

The document discusses the Collaborative Drug Discovery (CDD) platform, which aims to facilitate data sharing and collaboration in drug discovery. Key points: - CDD allows users to securely store private data while selectively sharing subsets with collaborators. It also hosts public datasets totaling over 3 million compounds. - CDD has been used to facilitate collaboration in neglected disease research, particularly for tuberculosis and malaria. It hosts over 15 public TB datasets totaling over 300,000 compounds. - Analysis of TB and malaria hit compounds on the platform shows generally higher molecular weights and logP values compared to approved drugs. Many compounds also fail filtering for undesirable reactivity.

Hartung - Lush Prize Conference 2014

LushPrize

This document summarizes the work of Thomas Hartung and the CAAT (Center for Alternatives to Animal Testing) team over several decades to advance alternative methods to animal testing. It discusses their efforts to promote better science through alternative methods that are less reliant on animals, more relevant to humans, and faster and cheaper. It outlines CAAT's work developing new tools and methods as well as establishing think tanks, policy programs, and collaborations across Europe and the US to validate and implement alternative approaches.

機械学習は化学研究の"経験と勘"を合理化できるか？

Ichigaku Takigawa

1) Machine learning can help rationalize the "experience and intuition" of chemical research by finding patterns and exceptions from large amounts of chemical data to predict new materials and phenomena. 2) While in theory chemical structures and properties can be described by Schrodinger's equation, it is impossible to solve for realistic systems, requiring approximations. Machine learning may help address this challenge. 3) Chemists have successfully created compounds with desired properties through "experience and intuition", which involves inductive reasoning from experiments rather than purely deductive logic, incorporating serendipitous findings.

Network analysis of cancer metabolism: A novel route to precision medicine

Varshit Dusad

This document discusses using network analysis and mass flow graphs to analyze cancer cell metabolism. It assesses different published genome-scale metabolic models of cancer and determines that PRIME models are best suited for applying mass flow graph analysis. Constraint-based analysis is performed on PRIME models to simulate metabolic conditions and genetic perturbations. Centrality analysis using PageRank reveals changes in network structure under different conditions but does not fully support the centrality-lethality hypothesis regarding essential reactions. Future work is needed to better integrate omics data and identify centrality measures that correlate with biological importance.

Alternative methods to animal toxicity testing

priyachhikara1

This document discusses alternative methods to animal toxicity testing, including in silico computer simulation methods, in vitro cell culture techniques, using fewer animals, microdosing, and epidemiological and clinical studies. It provides details on regulatory agencies that promote alternative testing methods, as well as specific alternative tests that have been developed and validated according to OECD guidelines to replace or reduce animal use.

Bioinformatics t9-t10-biocheminformatics v2014

Prof. Wim Van Criekinge

This document discusses various topics related to drug discovery through bioinformatics. It begins by describing how genome-wide RNAi screening in the nematode C. elegans can be used to identify genes involved in biological pathways related to diseases like type-2 diabetes. It then discusses topics like structural genomics, target identification and validation, high-throughput screening approaches and facilities, sources for screening libraries, criteria for hit and lead compounds, and computational methods used in hit identification and optimization like pharmacophore modeling and evaluating compounds against the "rule of five". Descriptors that can be used for characterizing compounds are also listed.

Collaborative Database and Computational Models for Tuberculosis Drug Discovery

Sean Ekins

Collaborative databases and computational models can help tuberculosis (TB) drug discovery efforts. The author describes a collaborative drug discovery (CDD) platform that allows researchers to securely share private data and selectively share subsets with collaborators. Bayesian classification models built on large TB datasets from this platform can predict compound activity with over 75% accuracy. Integrating cytotoxicity data improves model performance. Collaborations using this platform have identified potential TB drug leads in less than 6 months.

Nc state lecture v2 Computational Toxicology

Sean Ekins

The document discusses computational approaches to modeling various aspects of toxicology, including physicochemical properties, quantitative structure-activity relationships, and interactions with proteins and pathways involved in toxicity. It provides examples of modeling properties like solubility and lipophilicity, as well as targets like cytochrome P450 enzymes and the pregnane X receptor. Statistical methodologies for building predictive models are also reviewed. The future of crowdsourced drug discovery is briefly mentioned.

Residual solvent analysis, part 3 Solvents’ Limit in Pharmaceuticals with “N...

Alba Casta Pharma Solutions, India

Solvents, not grouped in Class-1, Class-2 and Class-3, are often required to attain desirable properties of drug substances, products and excipients. Their use is particularly important in drug substances where a specific polymorph determines the bioavailability of drug product. How the limit of of such solvents is determined in pharmaceuticals, is the topic and content of this video. Further what other strategies are made available to regulatory personnel to justify such solvents' limits in pharmaceuticals.

Drug Discovery Today: Fighting TB with Technology

rendevilla

This document discusses desktop drug discovery and development using computational methods. It covers rational drug design approaches like computer-aided drug design (CADD), targeting identification and validation, lead discovery and optimization, and preclinical testing using molecular modeling and simulation. Specific examples are provided of structure-based drug design against targets for tuberculosis and the preclinical evaluation of candidate compounds.

Virtual screening of chemicals for endocrine disrupting activity through CER...

Kamel Mansouri

Endocrine disrupting chemicals (EDCs) are xenobiotics that mimic the interaction of natural hormones at the receptor level and alter synthesis, transport and metabolism pathways. The prospect of EDCs causing adverse health effects in humans and wildlife has led to the development of scientific and regulatory approaches for evaluating bioactivity. This need is being partially addressed by the use of high-throughput screening (HTS) in vitro approaches and computational modeling. In the framework of the Endocrine Disruptor Screening Program (EDSP), the U.S. EPA led two worldwide consortiums to “virtually” (i.e., in silico) screen chemicals for their potential estrogenic and androgenic activities. The Collaborative Estrogen Receptor (ER) Activity Prediction Project (CERAPP) [1] predicted activities for 32,464 chemicals and the Collaborative Modeling Project for Androgen Receptor (AR) Activity (CoMPARA) generated predictions on the CERAPP list with additional simulated metabolites, totaling 55,450 unique structures. Modelers and computational toxicology scientists from 30 international groups contributed structure-based models and results for activity prediction to one or both projects, with methods ranging from QSARs to docking to predict binding, agonism and antagonism activities. Models were based on a common training set of 1746 chemicals having ToxCast/Tox21 HTS in vitro assay results (18 assays for ER and 11 for AR) integrated into computational networks. The models were then validated using curated literature data from different sources (~7,000 results for ER and ~5,000 results for AR). To overcome the limitations of single approaches, CERAPP and CoMPARA models were each combined into consensus models reaching high predictive accuracy. These consensus models were extended beyond the initially designed datasets by implementing them into the free and open-source application OPERA to avoid running every single model on new chemicals [2]. This implementation was used to screen the entire EPA DSSTox database of ~750,000 chemicals and predicted ER and AR activity is made freely available on the CompTox Chemistry dashboard (https://comptox.epa.gov/dashboard) [3].

Bigger Data to Increase Drug Discovery

Sean Ekins

2013-11-26 DTL FIH symposium, Leiden

Alain van Gool

1) The document discusses the use of protein and metabolite biomarkers in personalized healthcare, noting that over 100 biomarkers are now included in drug labels and 16 companion diagnostics are needed. 2) It describes how companion diagnostics can help determine a drug's metabolism, efficacy, or safety for a patient. Systems biology approaches that integrate multi-omic data are important for developing personalized treatment approaches. 3) The Radboud Center for Proteomics, Glycomics and Metabolomics performs various 'omics analyses including proteomics, glycoproteomics, metabolomics, and top-down proteomics to discover and validate biomarkers for personalized healthcare applications like diagnosing rare diseases, detecting inborn errors of metabolism, and characterizing

Toxicological information in PubChem

Sunghwan Kim

Presented at the Fall 2020 American Chemical Society (ACS) National Meeting (Virtual) on August 20, 2020. Sunghwan Kim, Jian Zhang, Paul Thiessen, Asta Gindulyte, Pertti J. Hakkinen & Evan Bolton National Library of Medicine, National Institutes of Health, Rockville, Maryland, United States ==== Abstract ==== PubChem (https://pubchem.ncbi.nlm.nih.gov) is a public chemical information resource at the U.S. National Institutes of Health. It collects chemical information from 700+ data sources and disseminates the collected data to the public free of charge. Arguably, PubChem contains the largest amount of chemical information available in the public domain, with more than 250 million depositor-provided substance descriptions, 100 million unique chemical structures, and 265 million bioactivity outcomes from one million assays covering around twenty thousand unique protein target sequences. Included in the many types of content in PubChem is toxicological information about chemicals, e.g., human and animal toxicity, ecotoxicity, exposure limits, exposure symptoms, and antidote & emergency treatment. Notably, a substantial amount of toxicological information from resources formerly offered by the TOXicology data NETwork (TOXNET) is now integrated into PubChem, e.g., the Hazardous Substances Data Bank (HSDB), LactMed, and LiverTox. In addition, PubChem contains a large amount of bioactivity and toxicity screening data that can be used to build toxicity prediction models based on statistical and machine-learning approaches. This presentation provides an overview of PubChem’s toxicological information as well as tools and services that help users exploit this information. It also describes how open data in PubChem can be used to develop prediction models for chemical toxicity.

Consensus Models to Predict Endocrine Disruption for All Human-Exposure Chemi...

Kamel Mansouri

AAAS annual meeting (Boston, Feb 2017) Humans are potentially exposed to tens of thousands of man-made chemicals in the environment. It is well known that some environmental chemicals mimic natural hormones and thus have the potential to be endocrine disruptors. Most of these environmental chemicals have never been tested for their ability to disrupt the endocrine system, in particular, their ability to interact with the estrogen receptor. EPA needs tools to prioritize thousands of chemicals, for instance in the Endocrine Disruptor Screening Program (EDSP). Collaborative Estrogen Receptor Activity Prediction Project (CERAPP) was intended to be a demonstration of the use of predictive computational models on HTS data including ToxCast and Tox21 assays to prioritize a large chemical universe of 32464 unique structures for one specific molecular target – the estrogen receptor. CERAPP combined multiple computational models for prediction of estrogen receptor activity, and used the predicted results to build a unique consensus model. Models were developed in collaboration between 17 groups in the U.S. and Europe and applied to predict the common set of chemicals. Structure-based techniques such as docking and several QSAR modeling approaches were employed, mostly using a common training set of 1677 compounds provided by U.S. EPA, to build a total of 42 classification models and 8 regression models for binding, agonist and antagonist activity. All predictions were evaluated on ToxCast data and on an external validation set collected from the literature. In order to overcome the limitations of single models, a consensus was built weighting models based on their prediction accuracy scores (including sensitivity and specificity against training and external sets). Individual model scores ranged from 0.69 to 0.85, showing high prediction reliabilities. The final consensus predicted 4001 chemicals as actives to be considered as high priority for further testing and 6742 as suspicious chemicals. The same approach is now being applied on a larger scale project to predict the potential androgen receptor (AR) activity of chemicals. This project called CoMPARA (Collaborative Modeling Project for Androgen Receptor Activity) is a collaboration between 35 international groups working on a common set of ~55k chemicals. This abstract does not necessarily reflect U.S. EPA policy

BigData in Life Sciences, Genomics and Systems Biology

Harsha Rajasimha

DataScientist Job : Between Myths and Reality.pdf

Prévenir la toxicité d'une aliment grâce à la Data Science - Abdoul Traoré

Recommended

Recommended

More Related Content

Similar to Prévenir la toxicité d'une aliment grâce à la Data Science - Abdoul Traoré

Similar to Prévenir la toxicité d'une aliment grâce à la Data Science - Abdoul Traoré (20)

More from Jedha Bootcamp

More from Jedha Bootcamp (20)

Recently uploaded

Recently uploaded (20)

Prévenir la toxicité d'une aliment grâce à la Data Science - Abdoul Traoré